(Q41641082)

6 October 2017

title

Effect of Peg-interferon α-2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA. (English)

1 reference

6 October 2017

Junfeng Lu

1

1 reference

6 October 2017

Shibin Zhang

2

1 reference

6 October 2017

Yali Liu

3

1 reference

6 October 2017

Xiaofei Du

4

1 reference

6 October 2017

Shan Ren

5

1 reference

6 October 2017

Hua Zhang

6

1 reference

6 October 2017

Lina Ma

7

1 reference

6 October 2017

Yue Chen

8

1 reference

6 October 2017

Xinyue Chen

9

1 reference

6 October 2017

Chengli Shen

10

1 reference

6 October 2017

publication date

21 January 2015

1 reference

6 October 2017

1 reference

6 October 2017

volume

35

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

1692-1699

1 reference

Hepatitis B Virus Infection

6 October 2017

cites work

1 reference

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

21 January 2018

1 reference

Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.

21 January 2018

1 reference

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus

21 January 2018

1 reference

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b

21 January 2018

1 reference

Benefits and risks of interferon therapy for hepatitis B.

21 January 2018

1 reference

Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment

21 January 2018

1 reference

Management of hepatitis B: summary of a clinical research workshop

21 January 2018

1 reference

21 January 2018

1 reference

Chronic hepatitis B: update 2009

21 January 2018

1 reference

Cutting edge: IL-10-producing regulatory B cells in early human pregnancy.

21 January 2018

1 reference

Sequential treatment with lamivudine and alpha-interferon in anti-HBe-positive chronic hepatitis B patients: a pilot study

21 January 2018

1 reference

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

21 January 2018

1 reference

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

Protection of hepatocytes from cytotoxic T cell mediated killing by interferon-alpha

21 January 2018

1 reference

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

21 January 2018

1 reference

Reduction of HBV replication prolongs the early immunological response to IFNα therapy

21 January 2018

1 reference

Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog

21 January 2018

1 reference

Postpartum subsidence of hepatitis B viral replication in hbeag-positive carrier mothers

21 January 2018

1 reference

Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: Correlation with viral characteristics

21 January 2018

1 reference

Sequential therapy with adefovir dipivoxil and pegylated Interferon Alfa-2a for HBeAg-negative patients

21 January 2018

1 reference

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12753

1 reference

6 October 2017

1 reference